A new magnetically assisted wastewater treating system has been suggested for CrVI-contaminated waters using a novel and strong Cr-sorbent, namely, schwertmannite. The system contains a fixed-bed column, put in a high magnetic field, which was alternately packed with schwertmannite fine particles and iron wools as a ferromagnetic porous media. The obtained results confirm its high efficiency.

No description available.

Thesis submitted in fulfilment of the requirements for the Degree Master of Technology: Chemical Engineering in the Faculty Of Engineering at the Cape Peninsula University of Technology / It is known when synthesising nanomaterial on laboratory scale, a variation in a single synthesis parameter may alter the product. Numerous synthesis techniques have been employed in the synthesis of titanium dioxide with varying phase, size and shape. It was found that changes in the phase directly affect their properties and application, such as treating of textile wastewater by photodegradation. However, when synthesising nanoparticles, changes to any reaction parameters and/or kinetics can have a desirable or undesirable effect on titanium dioxide nanoparticles. There is therefore a need to understand how HCl acid concentration (homogeneous catalyst) and shortened gel formation duration affect synthesis of TiO2 nanoparticles and photocatalytic properties. A sol-gel followed by hydrothermal treatment was employed to synthesise 2.8 grams of titanium dioxide nanorods for the duration of 96 hours, initially. A systematic study was conducted to exploit reaction kinetics by varying HCl acid concentration (3, 4, 5 molar), water feed for TiO2 gel formation (72, 24, 12 hours), and hydrothermal treatment time for the transformation of gel to crystalline TiO2 (1–20 hours). The photocatalytic activity of synthesised TiO2 nanoparticle was evaluated, when irradiated with a UV-C bulb to degrade an industrial textile dye, methylene blue. Systematic studies were successful in identifying the effects HCl acid concentration, gel formation time and lengthened hydrothermal treatment time have on TiO2 nanoparticles’ phase, size and shape. Increased HCl concentrations for shortened gel formation times resulted in mixed phases of TiO2, decreases in particle size and particle shape deformed from nanorods. Increased photocatalytic activity was found for a decrease in the rutile and increase in the brookite phase percentage, but this plateaued after 42% brookite phase. Furthermore, lengthened hydrothermal treatment assisted in phase transformation of particles synthesised at shortened gel formation times for high HCl acid concentrations. Pure rutile TiO2 was synthesised at a sixth of the initial synthesis time. Furthermore, the effects of changes in nanoparticles on the photocatalytic activity was discussed. Moreover, exploiting reaction kinetics resulted in the synthesis of a more efficient photocatalytically active TiO2 nanoparticle sample at shortened synthesis time.

Class of 2005 Abstract / Objective: The goal of this study was to determine the presence of erythro-methylphenidate (erythro-MPH) isomers contained within methylphenidate HCl (Metadate CD®) capsules. Methods: This experiment was conducted at a pharmaceutical manufacturing facility located in Tucson, Arizona. Methylphenidate HCl (MPH) capsules by Celltech Pharmaceuticals, Inc. were analyzed and compared to a reference standard. Thin-layer chromatography (TLC) was the technique used to qualitate the samples. The main outcome measure was the Rf values which were used to determine whether or not the MPH capsules contained erythro-MPH. Results: The study included ten, 20 mg MPH capsules and a reference standard (50 mg strength USP MPH related compound). The Rf value of the reference standard was 0.073 while the Rf value of the MPH samples ranged from 0.42 - 0.85. Conclusion: In this qualitative analysis of MPH capsules, there was no erythro-MPH isomers present in the MPH capsules.

Master of Science / Department of Animal Sciences and Industry / John M. Gonzalez / Pigs fed ractopamine-HCl (RAC) are more prone to fatigue and exhaustion when improperly handled. Wireless electromyography (EMG) can be used to directly measure median power frequency (MdPF) and root mean square (RMS) as indicators of action potential conduction velocity and muscle fiber recruitment, respectively. The objectives of this study were to determine the effect of RAC on exhaustion, EMG measures, and muscle fiber type characteristics when barrows were subjected to increased levels of activity. Thirty-four barrows were assigned to one of two treatments: a commercial finishing diet containing 0 mg/kg (CON) RAC or a diet formulated to meet the requirements of finishing barrows fed 10 mg/kg RAC (RAC+) for 35 d. After 32 d of feeding, barrows were walked around a circular track at 0.79 m/s until subjective exhausted was reached. Time, distance, and speed were measured. Wireless surface EMG sensors were affixed to the Deltoideus (DT), Triceps brachii lateral head (TLH), Tensor fasciae latae (TFL), and Semitendinosus (ST) muscles. After harvest, samples of each muscle were collected for fiber type, succinate dehydrogenase, and capillary density analysis. Speed was not different (P = 0.82) between treatments, but RAC+ barrows reached subjective exhaustion quicker and covered less distance than CON barrows (P < 0.01). The end-point MdPF was not affected by the RAC diet. The RAC diet did not change end-point RMS values in the DT or TLH; however, the RAC+ barrows tended to have decreased ST and increased TFL end-point RMS values (P < 0.07). The percentage of type I fibers tended to be greater (P = 0.07) in RAC+ barrows, but the RAC diet tended to increase (P = 0.07) size of type I fibers and increase (P = 0.03) the size of type IIA fibers. Succinate dehydrogenase was not different between treatments. The RAC+ barrows had more (P = 0.03) capillaries per fiber than CON barrows. A diet containing RAC contributes to increased onset of subjective exhaustion, possibly due to rapid loss of active muscle fibers and chronic loss of oxidative muscle fibers with no change in muscle metabolism.

Mobilization of colloidal particulate matter (most important, clay particles) from a soil matrix in the subsurface environment is an important environmental process. As many contaminants tend to adsorb onto various colloidal mineral particles, co-transport of contaminants in association with mobilized particles could contribute significantly to the migration of these contaminants in the environment. Numerous studies have observed the effects of pH on colloid mobilization but have overlooked the possible direct role of acidity. This study looked at the role of acidity with H⁺ as a chemical agent. Through cyclic elution of a natural sand column with a weak acid and base solution, there was an increase in mobilized clay colloids. It was found that low concentrations of organic acids could assist in detaching surface clays through lysing of labile Ca²⁺ and Mg²⁺ ions. The H⁺ ions sever the chemical bonds between the grain surface and the colloidal surface by being substituted for the interstitial Ca and Mg ions. This substitution has been found to release over 1 kg of surface clay per 1 mole of H⁺ consumed. It was postulated that pH oscillation addition to proton dynamics could play a major role in subsurface colloid transport. The results from this study could help improve predicting of subsurface contaminant fronts and aid in managing contaminant transport in the soil water environments.

Local anaesthetics are used regularly in the medical world for a variety of different procedures. Topical anaesthetics are used largely in minor skin breaking procedures, laceration repair and minor surgical procedures such as laryngoscopy, oesophagoscopy or urethroscopy (Franchi et al., 2008:186e1). The topical means of application of a local anaesthetic is non-invasive and painless that results in a good patient acceptability profile (Little et al., 2008:102). An existing commercial topical anaesthetic product contains a eutectic mixture of the amide-type local anaesthetics lidocaine hydrochloride (HCl) and prilocaine hydrochloride (HCl). This commercial product takes up to an hour to produce an anaesthetic effect. This is considered as a disadvantage in the use of topical anaesthetics, an hour waiting time is not always ideal in certain medical circumstances (Wahlgren & Quiding, 2000:584). This study compared the lag times, transdermal and topical delivery of lidocaine HCl and prilocaine HCl from four different semi-solid formulations with the inclusion of a current commercial product. One of the formulated semi-solid formulations included Pheroid™ technology, a novel skin-friendly delivery system developed by the Unit for Drug Research and Development at the North-West University, Potchefstroom Campus, South Africa. The skin is the body’s first line of defence against noxious external stimuli. It is considered the largest organ in the body with an intensive and complex structure. It consists of five layers with the first outer layer, the stratum corneum, the most impermeable (Williams, 2003:1). The stratum corneum has excellent barrier function characteristics and is the cause for the time delay in the transdermal delivery of active pharmaceutical ingredients (API) (Barry, 2007:569). Local anaesthetics need to penetrate all the epidermal skin layers in order to reach their target site, the dermis. Skin appendages as well as blood vessels and skin nerve endings are located in the dermis. Local anaesthetics have to reach the free nerve endings in the dermis in order to cause a reversible block on these nerves for a local anaesthetic effect (Richards & McConachie, 1995:41). Penetration enhancement strategies for the transdermal delivery of lidocaine and prilocaine have been investigated and include methods like liposomal entrapment (Franz-Montan et al., 2010; Müller et al., 2004), micellisation (Scherlund et al., 2000), occlusive dressing (Astra Zeneca, 2006), heating techniques (Masud et al., 2010) and iontophoresis (Brounéus et al., 2000). The Pheroid™ delivery system has improved the transdermal delivery of several compounds with its enhanced entrapment capabilities. Pheroid™ consists mainly of unsaturated essential fatty-acids, non-harmful substances that are easily recognised by the body (Grobler et al., 2008:285). The morphology and size of Pheroid™ is easily manipulated because it is a submicron emulsion type formulation which provides it with a vast flexibility profile (Grobler et al., 2008:284). Vesicular entrapment was used to entrap lidocaine HCl and prilocaine HCl in the Pheroid™ and incorporated into an emulgel formulation. An emulgel without the inclusion of Pheroid™ was formulated for comparison with the Pheroid™ emulgel as well as with a hydrogel. Pheroid™ solution was prepared and compared to a phosphate buffer solution (PBS) without Pheroid™, both containing lidocaine HCl and prilocaine HCl as APIs. Franz cell type transdermal diffusion studies were performed on the four semi-solid formulations (emulgel, Pheroid™ emulgel, hydrogel and the commercial product) and two solutions (PBS and Pheroid™). The diffusion studies were performed over a 12 h period followed by the tape stripping of the skin after each diffusion study. Caucasian female abdominal skin was obtained with consent from the donors. The skin for the diffusion cells were prepared by using a Zimmer Dermatome®. PBS (pH 7.4) was prepared as the receptor phase of the diffusion studies. The receptor phase was extracted at certain pre-determined time intervals and analysed with high performance liquid chromatography (HPLC) to determine the amount of API that had traversed the skin. Stratum corneum-epidermis samples and epidermis-dermis samples were prepared and left over night at 4 °C and analysed the next day with HPLC. This was done to determine the amount of API that accumulated in the epidermis-dermis and the amount of API that were left on the outer skin layers (stratum corneum-epidermis). The results from the Franz cell diffusion studies indicated that the emulgel formulation without Pheroid™ shortened the lag time of lidocaine HCl and that the emulgel formulated with Pheroid™ shortened the lag time of prilocaine HCl, when compared to the commercial product. Pheroid™ did not enhance the flux of lidocaine HCl and prilocaine HCl into the skin. The hydrogel formulation demonstrated a high transdermal flux of prilocaine HCl due to the hydrating effect it had on the stratum corneum. The commercial product yielded high flux values for both APIs but it did not result in a high concentration of the APIs delivered to the epidermis-dermis. Pheroid™ technology did, however, enhance the epidermal-dermal delivery of lidocaine HCl and prilocaine HCl into the skin epidermis-dermis. The stability of the emulgel formulation, Pheroid™ emulgel formulation and the hydrogel formulation was examined over a 6 month period. The formulations were stored at 25 °C/60% RH, 30 °C/60% RH and 40 °C/75% RH. The API concentration, mass, pH, zeta potential, particle size, viscosity and visual appearance for each formulation at the different storage conditions were noted and compared at month 0, 1, 2, 3 and 6 to determine if the formulations remained stable for 6 months. The results obtained from the stability study demonstrated that none of the formulations were stable for 6 months. The emulgel remained stable for the first 3 months. At 6 months, large decreases in API concentration and pH occurred which could cause a loss of anaesthetic action in the formulations. The Pheroid™ emulgel formulation did not remain stable for 6 months. / Thesis (MSc (Pharmaceutics))--North-West University, Potchefstroom Campus, 2013.

Local anaesthetics are used regularly in the medical world for a variety of different procedures. Topical anaesthetics are used largely in minor skin breaking procedures, laceration repair and minor surgical procedures such as laryngoscopy, oesophagoscopy or urethroscopy (Franchi et al., 2008:186e1). The topical means of application of a local anaesthetic is non-invasive and painless that results in a good patient acceptability profile (Little et al., 2008:102). An existing commercial topical anaesthetic product contains a eutectic mixture of the amide-type local anaesthetics lidocaine hydrochloride (HCl) and prilocaine hydrochloride (HCl). This commercial product takes up to an hour to produce an anaesthetic effect. This is considered as a disadvantage in the use of topical anaesthetics, an hour waiting time is not always ideal in certain medical circumstances (Wahlgren & Quiding, 2000:584). This study compared the lag times, transdermal and topical delivery of lidocaine HCl and prilocaine HCl from four different semi-solid formulations with the inclusion of a current commercial product. One of the formulated semi-solid formulations included Pheroid™ technology, a novel skin-friendly delivery system developed by the Unit for Drug Research and Development at the North-West University, Potchefstroom Campus, South Africa. The skin is the body’s first line of defence against noxious external stimuli. It is considered the largest organ in the body with an intensive and complex structure. It consists of five layers with the first outer layer, the stratum corneum, the most impermeable (Williams, 2003:1). The stratum corneum has excellent barrier function characteristics and is the cause for the time delay in the transdermal delivery of active pharmaceutical ingredients (API) (Barry, 2007:569). Local anaesthetics need to penetrate all the epidermal skin layers in order to reach their target site, the dermis. Skin appendages as well as blood vessels and skin nerve endings are located in the dermis. Local anaesthetics have to reach the free nerve endings in the dermis in order to cause a reversible block on these nerves for a local anaesthetic effect (Richards & McConachie, 1995:41). Penetration enhancement strategies for the transdermal delivery of lidocaine and prilocaine have been investigated and include methods like liposomal entrapment (Franz-Montan et al., 2010; Müller et al., 2004), micellisation (Scherlund et al., 2000), occlusive dressing (Astra Zeneca, 2006), heating techniques (Masud et al., 2010) and iontophoresis (Brounéus et al., 2000). The Pheroid™ delivery system has improved the transdermal delivery of several compounds with its enhanced entrapment capabilities. Pheroid™ consists mainly of unsaturated essential fatty-acids, non-harmful substances that are easily recognised by the body (Grobler et al., 2008:285). The morphology and size of Pheroid™ is easily manipulated because it is a submicron emulsion type formulation which provides it with a vast flexibility profile (Grobler et al., 2008:284). Vesicular entrapment was used to entrap lidocaine HCl and prilocaine HCl in the Pheroid™ and incorporated into an emulgel formulation. An emulgel without the inclusion of Pheroid™ was formulated for comparison with the Pheroid™ emulgel as well as with a hydrogel. Pheroid™ solution was prepared and compared to a phosphate buffer solution (PBS) without Pheroid™, both containing lidocaine HCl and prilocaine HCl as APIs. Franz cell type transdermal diffusion studies were performed on the four semi-solid formulations (emulgel, Pheroid™ emulgel, hydrogel and the commercial product) and two solutions (PBS and Pheroid™). The diffusion studies were performed over a 12 h period followed by the tape stripping of the skin after each diffusion study. Caucasian female abdominal skin was obtained with consent from the donors. The skin for the diffusion cells were prepared by using a Zimmer Dermatome®. PBS (pH 7.4) was prepared as the receptor phase of the diffusion studies. The receptor phase was extracted at certain pre-determined time intervals and analysed with high performance liquid chromatography (HPLC) to determine the amount of API that had traversed the skin. Stratum corneum-epidermis samples and epidermis-dermis samples were prepared and left over night at 4 °C and analysed the next day with HPLC. This was done to determine the amount of API that accumulated in the epidermis-dermis and the amount of API that were left on the outer skin layers (stratum corneum-epidermis). The results from the Franz cell diffusion studies indicated that the emulgel formulation without Pheroid™ shortened the lag time of lidocaine HCl and that the emulgel formulated with Pheroid™ shortened the lag time of prilocaine HCl, when compared to the commercial product. Pheroid™ did not enhance the flux of lidocaine HCl and prilocaine HCl into the skin. The hydrogel formulation demonstrated a high transdermal flux of prilocaine HCl due to the hydrating effect it had on the stratum corneum. The commercial product yielded high flux values for both APIs but it did not result in a high concentration of the APIs delivered to the epidermis-dermis. Pheroid™ technology did, however, enhance the epidermal-dermal delivery of lidocaine HCl and prilocaine HCl into the skin epidermis-dermis. The stability of the emulgel formulation, Pheroid™ emulgel formulation and the hydrogel formulation was examined over a 6 month period. The formulations were stored at 25 °C/60% RH, 30 °C/60% RH and 40 °C/75% RH. The API concentration, mass, pH, zeta potential, particle size, viscosity and visual appearance for each formulation at the different storage conditions were noted and compared at month 0, 1, 2, 3 and 6 to determine if the formulations remained stable for 6 months. The results obtained from the stability study demonstrated that none of the formulations were stable for 6 months. The emulgel remained stable for the first 3 months. At 6 months, large decreases in API concentration and pH occurred which could cause a loss of anaesthetic action in the formulations. The Pheroid™ emulgel formulation did not remain stable for 6 months. / Thesis (MSc (Pharmaceutics))--North-West University, Potchefstroom Campus, 2013.

Master of Science / Animal Sciences and Industry / John M. Gonzalez / Pigs fed ractopamine-HCl (RAC) are more prone to fatigue and exhaustion when improperly handled. Wireless electromyography (EMG) can be used to directly measure median power frequency (MdPF) and root mean square (RMS) as indicators of action potential conduction velocity and muscle fiber recruitment, respectively. The objectives of this study were to determine the effect of RAC on exhaustion, EMG measures, and muscle fiber type characteristics when barrows were subjected to increased levels of activity. Thirty-four barrows were assigned to one of two treatments: a commercial finishing diet containing 0 mg/kg (CON) RAC or a diet formulated to meet the requirements of finishing barrows fed 10 mg/kg RAC (RAC+) for 35 d. After 32 d of feeding, barrows were walked around a circular track at 0.79 m/s until subjective exhausted was reached. Time, distance, and speed were measured. Wireless surface EMG sensors were affixed to the Deltoideus (DT), Triceps brachii lateral head (TLH), Tensor fasciae latae (TFL), and Semitendinosus (ST) muscles. After harvest, samples of each muscle were collected for fiber type, succinate dehydrogenase, and capillary density analysis. Speed was not different (P = 0.82) between treatments, but RAC+ barrows reached subjective exhaustion quicker and covered less distance than CON barrows (P < 0.01). The end-point MdPF was not affected by the RAC diet. The RAC diet did not change end-point RMS values in the DT or TLH; however, the RAC+ barrows tended to have decreased ST and increased TFL end-point RMS values (P < 0.07). The percentage of type I fibers tended to be greater (P = 0.07) in RAC+ barrows, but the RAC diet tended to increase (P = 0.07) size of type I fibers and increase (P = 0.03) the size of type IIA fibers. Succinate dehydrogenase was not different between treatments. The RAC+ barrows had more (P = 0.03) capillaries per fiber than CON barrows. A diet containing RAC contributes to increased onset of subjective exhaustion, possibly due to rapid loss of active muscle fibers and chronic loss of oxidative muscle fibers with no change in muscle metabolism.

This work explored the viability of two solid adsorbents, limestone and cement powder, for use in a flow-through packed-bed column for HCl and HF gas neutralization following refrigerant destruction. Neutralization tests performed at 408 K using 5% HCl in N2 and 5% HF in N2, showed that limestone had a significantly higher adsorption capacity for both HF & HCl, future tests therefore utilized limestone only. The results showed that ~49% of the fed HCl and between 7.8% - 16.2% of the fed HF gases were adsorbed by 0.007 kg of limestone for a 6.67×10-6 m3/s (STP) flow rate over 30 – 180 minutes. Applying the shrinking core model, effective diffusivities (De) of HCl & HF into the limestone particles were 1.5×10-9 & 2.2×10-9 m2/s respectively. Under these conditions, complete particle conversion times were 227 hours for HCl–limestone and 154 hours for HF–limestone. Estimating De values at plasma-reactor temperatures gave 5.61x10-9 m2/s & 8.24x10-9 m2/s for HCl–limestone and HF–limestone respectively. Correspondingly, particle consumption times were reduced to 61 and 41 hours for HCl–limestone and HF–limestone. Considering the conversion times for the 1 mm particle sizes, shorter conversion times would require micron-scale particle sizes, suitable for entrained flow but not for a packed-bed arrangement.